Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Metastasis02:30

Metastasis

5.9K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.9K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

6.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
Tumor Immunotherapy01:27

Tumor Immunotherapy

759
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
759
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

5.0K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
5.0K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

76.2K
Overview
76.2K
The Tumor Microenvironment02:17

The Tumor Microenvironment

7.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mimicking a Light-Harvesting Complex to Accelerate Photooxidation in Asymmetric Lipid Membrane Nanoreactors.

Angewandte Chemie (International ed. in English)·2026
Same author

Hedgehog Inhibitor and Paclitaxel: A Phase I Trial of the Oral Hedgehog inhibitor Taladegib in Combination with Weekly Paclitaxel in Patients with Advanced Solid Tumours.

Investigational new drugs·2026
Same author

Electrophilic compound screening identifies GPX4-dependent ferroptosis as a senescence vulnerability.

Nature cell biology·2026
Same author

Patient-derived organoid xenografts reveal the multifaceted role of the lncRNA <i>MALAT1</i> in breast cancer progression.

bioRxiv : the preprint server for biology·2026
Same author

Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Nature communications·2026
Same author

Molecular Pathology, Artificial Intelligence, and New Technologies in Hematologic Diagnostics: Translational Opportunities and Practical Considerations.

Diagnostics (Basel, Switzerland)·2026

Related Experiment Video

Updated: Oct 21, 2025

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model
08:06

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model

Published on: November 26, 2010

19.8K

Activating a collaborative innate-adaptive immune response to control metastasis.

Lijuan Sun1, Tim Kees1, Ana Santos Almeida1

  • 1Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA.

Cancer Cell
|September 3, 2021
PubMed
Summary

Polarizing macrophages with monophosphoryl lipid A (MPLA) and interferon (IFN) gamma effectively targets cancer metastasis. This approach reprograms tumor-associated macrophages (TAMs) and activates T cells, offering a novel strategy for cancer immunotherapy.

Keywords:
IFNγMPLAanti-tumor immune responsebreast cancercytotoxic T cellsmetastasis treatmentovarian cancertumor-associated macrophages

More Related Videos

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.6K
Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis
07:45

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis

Published on: January 26, 2024

2.2K

Related Experiment Videos

Last Updated: Oct 21, 2025

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model
08:06

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model

Published on: November 26, 2010

19.8K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.6K
Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis
07:45

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis

Published on: January 26, 2024

2.2K

Area of Science:

  • Immunology
  • Oncology
  • Cancer Research

Background:

  • Tumor-associated macrophages (TAMs) often promote cancer metastasis and suppress anti-tumor immune responses.
  • Macrophages possess the plasticity to be polarized towards an anti-cancer phenotype.

Purpose of the Study:

  • To investigate the potential of polarizing macrophages using monophosphoryl lipid A (MPLA) and interferon (IFN) gamma as a cancer treatment strategy.
  • To evaluate the efficacy of MPLA + IFNγ in reducing tumor growth, metastasis, and enhancing chemotherapy response.

Main Methods:

  • Macrophages from breast cancer patient effusions were polarized with MPLA + IFNγ.
  • The combination therapy was administered intratumorally and intraperitoneally in breast and ovarian cancer mouse models.
  • Immune cell populations, signaling pathways (Type I IFN), and cytokine production (IL-12, TNFα) were analyzed.

Main Results:

  • MPLA + IFNγ treatment reduced primary tumor growth and metastasis in breast cancer models.
  • The therapy suppressed metastasis and improved chemotherapy response in an ovarian cancer model.
  • Treatment activated cytotoxic T cells and reprogrammed CD206+ TAMs to iNOS+ macrophages, mediated by IL-12 and TNFα.

Conclusions:

  • Macrophage polarization with MPLA + IFNγ is a viable strategy for controlling cancer progression and metastasis.
  • Both macrophages and T cells are crucial for the observed anti-metastatic effects.
  • This combination therapy harnesses innate and adaptive immunity for a systemic anti-tumor response, representing a novel clinical approach.